1. Introduction
In present times, bacterial drug resistance can lead to serious health problems worldwide due to the long-term use of traditional antibiotics resulting in bacteria becoming immune to treatment [
1]. Finding new antibiotics is becoming more and more difficult, and, therefore, new types of antibacterial compounds or novel innovative therapeutic approaches should be designed to solve this growing medical problem, being one of the top priorities for 2020, according to the World Health Organization (WHO). In this context, metal nanoparticles, based on their physical and chemical properties, have been recently proposed as versatile nanoplatforms of high research interest [
2]. In particular, although silver nanoparticles were proved to be very effective against bacteria strains [
3], presenting antimicrobial activity both in the dark and under illumination [
4,
5], an important concern is still represented by their induced cytotoxicity, thus limiting their implementation in biological applications. However, certain innovative safety systems were designed by D’Agostino et al. based on triangular silver nanoparticles which successfully proved their ability to act as powerful antimicrobial agents, by simply merging the controlled release of a very low concentration of silver ions in water with the hyperthermia effect generated by the photo-thermal activation under NIR irradiation at 808 nm. More interesting, the long-term antibacterial protection can be reinforced as needed by a fast, localized photothermal activation of the anisotropic-shaped silver nanoparticles, consequently ensuring an additional elimination of the bacterial cells [
6,
7]. On the other hand, gold nanoparticles exhibit low toxicity [
8,
9]; however, sometimes their intrinsic size and shape-dependent antibacterial activity seems to be insufficient. To overcome this problem, the surface modification of the plasmonic nanoparticles could be an answer, through use of controlled grafting of different charged molecules facilitating specific binding to the bacterial membrane, and, consequently, generating an increase of their antibacterial activity [
10]. Taking profit of the tunable sizes and shapes, as well as their easy surface functionalization, differently-functionalized gold nanoparticles started to be widely investigated as antibacterial, antifungal, antibiotic film platforms [
11]. For example, Scaiano’s group, using amoxicillin coating of the gold nanoparticles surface, proved synergistic antimicrobial activity upon light irradiation against sensitive and antibiotic-resistant
Staphylococcus aureus [
12], while by employing lignin as a natural reducing and capping agent, they demonstrated that these formed non-toxic nanocomposites are able to act as bacteriostatic agents against bacterial biofilms [
13]. However, by grafting onto the gold nanoparticles’ surface antimicrobial peptides (AMPs) [
14], well-known as natural antibiotics, it would be possible to significantly increase their antibacterial activity. In particular, AMPs are host defense peptides, most of them being cationic (positively charged, and thus the affinity for the negatively charged bacterial membrane is increased) and amphiphilic (hydrophilic and hydrophobic) α-helical peptide molecules. The negatively-charged membrane permeability is a well-accepted mechanism to describe the action of the cationic AMPs [
15], making them well suited for medical applications. Specifically, the AMPs first attach to the bacterial membrane through electrostatic interactions and is followed by the membrane disruption (due to the hydrophobic amino-acids), which is realized through three mechanisms: barrel-stave pore, toroidal pore or carpet model [
16,
17].
The free-standing paper structure, as a highly versatile, low-cost and biocompatible nanoplatform, can ensure better control of the cell distribution over the extracellular matrix, considering that this support, due to its porous, flexible and intrinsic three dimensional (3D) scaffolds, is able to mimic in a more realistic manner the in-vivo cell microenvironment [
18]. Additionally, paper has already been successfully implemented in a plethora of biological applications, starting as paper-based biosensors [
19,
20], 3D foldable paper electronics [
21], and, more recently, as a cell culture platform [
22,
23].
In the last decade, the use of nanotechnologies, which deal with the manipulation of nanomaterials and their controlled incorporation into paper platforms for decontamination purposes, has gained much attention. Different approaches have been designed to treat pathogens in real time [
24], as well as filter the water in order to clean the water sources. The development of affordable and efficient technological solutions is in great demand to battle bacterial pollution, so that the public can access safe drinking water and sanitation. In this context, Jain et al. developed a highly efficient filter paper, proposing a water-resistant cellulose foam paper with a high wetting strength property imbedded with diverse metal oxide (e.g., copper oxide (CuO), zinc oxide (ZnO), and silver oxide (Ag
2O)) nanoparticles, which was proved to be effective against different strains of bacteria [
25]. Nanoplatforms with antimicrobial properties were also obtained using ZnO and TiO
2 nanostructures grown on Whatman paper, presenting good results on
S. aureus bacteria [
26]. Therefore, paper, with its interesting large porous microstructure, offers not only the necessary space for cell growth, but also enables the incorporation of different nanomaterials, as well as its modification with different ligands of interest, such as peptides, consequently creating a more comfortable microenvironment for cell growth, and, thus, extending to different innovative applications.
In light of fighting against antibiotic-resistant bacteria, in this paper we propose a new 3D effective antibacterial platform realized in two successive steps: (i) the loading in a controlled and efficient manner of pre-synthesized positively charged cetyltrimethylammonium chloride (CTAC) spherical nanoparticles in colloidal solution onto Whatman paper, as a plasmonic matrix, followed by (ii) its surface functionalization with a synthetic polypeptide, specifically RRWHRWWRR-NH2 (denoted as P2). The gold nanoparticles, as antimicrobial nanomaterials, are used herein due to their many advantages, such as: (i) small size and high surface area; (ii) large contact area with bacteria, allowing the destruction of its permeability; (iii) reduced probability of different bacteria to develop drug-resistance to them, and, finally, (iv) low toxicity to mammalian cells compared to silver nanoparticles [
27]. While the successful functionalization of the plasmonic paper was demonstrated by the recorded spectral modifications in the localized surface plasmon resonance (LSPR) band and the emission band of the tryptophan residues before and after the P2 grafting, its biocompatibility was tested against human BJ cells. Then, the antimicrobial activity of the new-obtained platform was firstly evaluated on planktonic bacteria against two reference strains: Gram-positive bacteria, i.e.,
Staphylococcus aureus ATCC 12600 and the Gram-negative Bacteria, i.e.,
Escherichia coli ATCC 25922, proving an enhanced synergistic effect of 100% when P2 is grafted onto the nanoplatform compared to the free plasmonic paper. Furthermore, the plasmonic paper significantly reduces the in vitro biofilm formation of
Staphylococcus aureus up to 79% and
Escherichia coli up to 24% in contrast to the biofilm growth in the absence of the plasmonic paper. To summarize, our designed peptide-functionalized plasmonic paper can be a promising antimicrobial candidate in the future for treating wounds or skin infections.
3. Materials and Methods
3.1. Chemicals
Hydrogen tetrachloroaurate-(III) trihydrate (HAuCl4 ∙ 3H2O, 99.99%), sodium borohydride (NaBH4), Hexadecyltrimethylammonium bromide (CTAB, 96%), Cetyltrimethylammonium chloride solution (CTAC), ascorbic acid (AA) and Whatman® qualitative filter paper, Grade 1 (Whatman no. 1) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The synthetic RRWHRWWRR-NH2 polypeptide (further noted as P2) was synthetized by Pierce Protein Biology, Thermo Fisher Scientific (Mt Prospect, IL, USA). All chemicals were of analytical grade, and all aqueous solutions were prepared using ultrapure water (resistivity~18 MΩ).
3.2. Colloidal Gold Nanospherical Synthesis
For the fabrication of the CTAC-stabilized gold nanospheres (AuNSs), an adapted version of the successive seed-mediated growth approach previously reported by Zheng et al. [
33] was employed. The chemical synthesis method is based on two steps: (i) synthesis of initial CTAB-capped Au clusters by the addition of a NaBH
4 solution to a mixture containing 0.25 mM HAuCl
4 (as Au precursor) and 100 mM CTAB, and (ii) the generation of the CTAC-coated AuNSs from the Au clusters, which served as the initial seeds, by adding 10 µl of the as-synthesized Au clusters to a freshly prepared solution of 200 mM CTAC (serving as stabilizing agent) and AA (serving as reducing agents), followed by a 2 mL of 0.5 mM HAuCl
4 solution. The final mixture was then left to react for 15 min at 27 °C leading to the formation of Au seeds having 10 nm in diameter. The as-prepared seeds were then purified by centrifugation at 14.500 RTM for 30 min using a Mikro 220R from Hettich (Westphalia, Germany) centrifuge and redispersion in 20 mM CTAC solution.
3.3. Fabrication and Functionalization of the Plasmonic Paper Support
In order to fabricate the plasmonic paper substrate, Whatman no.1 filter paper was employed, from which paper strips were cut. For the immobilization of the nanoparticles, the strips were then immersed in the colloidal solution and left to soak for 10 min. The substrates were dried at 45 °C for an additional 10 min. To ensure a high loading of AuNSs on the paper fibers, the immobilized nanoparticle concentration was increased by the application of the immersion procedure for 3 consecutive times. The plasmonic paper was then functionalized with synthetic P2 polypeptide, by dropping 10 µL aqueous solution of 50 µM of P2 molecules to create a polypeptide monolayer on the plasmonic paper. To note that Peptide P2 was synthetized and characterized in a previous study together with 7 other de novo short tryptophan- and arginine-rich peptides [
31]. As reported, the 5 arginine residues (R) and the amidated C-terminus, give P2 a + 6 net charge, which will facilitate the electrostatic interaction with the negatively charged bacterial membrane. The peptide also has 3 tryptophan amino-acids (W), which facilitate the peptide insertion into lipid membranes. Based on previous results, P2, as well as peptides containing a RW pattern in their structure, have high antimicrobial properties. P2 exhibited MIC values between 5.2 and 25.6 µM against Gram positive (B. subtilis and S. aureus) and Gram negative bacteria (E. coli), with no hemolytic activity or cytotoxicity against lymphocytes at a concentration of 86.67 µM [
31].
3.4. Cell Culture
Human foreskin cell line, BJ was purchased from the ATCC Cell Line Bank, cultured in Modified Eagle’s medium (MEM), and supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin (1%−100 units/mL), in a humidified atmosphere of 95% air/5% CO2 at 37 °C. All cell cultivation media and reagents were purchased from Biochrom AG (Berlin, Germany).
The structural changes induced in the BJ cells by the paper support itself, AuNSs-immobilized and, subsequently, P2-functionalized plasmonic paper were investigated using fluorescence microscopy. For fluorescence imaging, the actin filaments were stained using Phalloidin-FITC (Sigma-Aldrich, St. Louis, MO, USA), while, for the nucleus, Hoechst 33342 (Invitrogen, Waltham, MA, USA.) was used, as briefly described. First, the BJ cells were grown on circular coverslips placed in 24 well plates at a density of 20,000 cells/well and grown for 24 h. Further, sterile discs having a diameter of 5 mm were cut from the bare Whatman paper (as control), AuNSs immobilized and P2-functionalized plasmonic substrates and placed inside the wells for an additional 24 h treatment. To note, that P2 alone was tested as well, and untreated cells were considered negative control. After the desired treatment time, the cells were washed with PBS and formaldehyde-fixed (PFA 4%). After this, the cells were washed again with PBS and permeabilized with Triton X-100 in PBS (0.1%). Then, an additional washing step was performed using PBS, followed by the permeabilization with Triton X-100 (0.1% in PBS). Subsequently, the treated BJ cells were washed again, then incubated with the two fluorescent dyes, in the dark, at room temperature for an hour and a half. Finally, the cells were washed with PBS and fixed with FluorSaveTM (Merck KGaA, Darmstadt, Germany).
3.5. In-Vitro Cell Viability Assay
The cell viability was assessed using a MTT assay, as briefly described [
34]. First, the BJ cells were plated into 24 well plates in similar conditions as mentioned above. After 24h of growing the cells in the presence of the nanoplatforms, the medium and the discs were removed from the wells, which were then incubated with a final concentration of 1 mg/mL of MTT. After 4 h, the medium was removed and DMSO was added to dissolve the formed crystals. The optical absorbance was recorded at 570 nm using the plate reader Mithras LB 940 (Berthold, Bad Wildbad, Germany) and the absorbance values of blank wells (only DMSO) were extracted in order to calculate the cell viability using the expression:
3.6. Bacterial Strains and Growth Conditions
For the antimicrobial activity assessment, two reference bacterial strains were tested, specifically the Gram-positive Staphylococcus aureus ATCC 12600 and Gram-negative Escherichia coli ATCC 25922 strains. The cultures of both strains were obtained by their incubation in Mueller-Hinton broth (Oxoid CM0405 Lot 2216266) for 2 h. The optical density of bacterial suspensions was calibrated spectrophotometrically at 0.5 McFarland standard equivalence and adjusted afterwards according to the requirements of each experimental method.
3.7. Antimicrobial Activity on Planktonic Bacteria
Prior to the antimicrobial tests, the plasmonic nanoplatforms were cut into discs having a diameter of 5 mm, which were then sterilised by the exposure to UV light for 15 min on each side. In order to evaluate the anti-bacterial activity of the plasmonic paper-based nanoplatform, half of the discs were implemented after the sterilization, while, for the assessment of the cumulated/combined activity with the P2 antimicrobial polypeptide, the other half was functionalized with a 50 µM P2 polypeptide solution and allowed to dry at 36 ± 1 °C for 1 h.
The colony-counting method was used firstly in a classical dilution-extraction variant. Using a 96 wells round bottom microtitration plate (M220 24A bioMerieux, Lot 1084), a quantity of 100 µL Mueller-Hinton broth per well was distributed in order to extract the antimicrobial soluble components, each disc being introduced in a corresponding well. Broth sterility and bacterial growth controls were added. After incubation for 24 h at 36 ± 1 °C, the discs were removed from the microtiter wells using sterile forceps and then 10 µL from a 10−2 dilution of a 0.5 McFarland bacterial suspension were added in all corresponding wells, except broth sterility and control well. After 24 h incubation at 36 ± 1 °C, 1 μL from each well was inoculated on blood agar in order to evaluate the bacterial growth.
Separately, the plasmonic paper discs with and without P2 after extraction as well as unsubmitted discs were distributed onto Mueller-Hinton agar inoculated with a 0.5 McFarland bacterial suspension for assessing the remaining antimicrobial activity using the disc diffusion method.
Furthermore, in order to substantiate the contribution of each component of our P2-functionalized paper-based nanoplatform to the antimicrobial activity, the bacterial cultures were calibrated at a turbidity equivalent with 0.5 McFarland standard and diluted to a final concentration of~102 UFC/mL. 1 mL of the Staphylococcus aureus and Escherichia coli diluted suspensions were placed in each of a series of 25 mL sterile glass tubes. The plasmonic discs with and without the P2 polypeptide were immersed in the bacterial suspension and maintained at 36 ± 1 °C in a shaking incubator for 24 h. After the incubation, 50 µL of each probe were extracted and diluted by factors ranging from 10−1 to 10−5. The obtained probes were inoculated on Columbia blood agar plates (Columbia agar OXOID CM 0331, Lot 2377465 added with 7% v/v sheep blood provided by Cantacuzino Institute Animalery) and incubated at 36 ± 1 °C for 24 h. Broth sterility control and bacterial growth control were also prepared in the same experimental conditions.
After the treatment, the plates with the appropriate dilution rate, which lead to isolated colonies, were further selected. The number of colony forming units (CFU) per milliliter was determined according to the equation:
where
n = the number of colonies counted on the plate, V = volume factor and D = dilution factor.
The growth reduction percent was calculated for all samples after the exposure to both
Staphylococcus aureus and
Escherichia coli using the following expression:
The antimicrobial activity was determined in triplicate for both treated with the plasmonic paper-based nanoplatform with and without P2, and control group samples.
3.8. Antimicrobial Activity on Bacterial Biofilms
The determination of the antimicrobial activity on biofilms was performed on static microplate biofilm assays. The plasmonic nanoplatform discs were placed in round bottom microplate (M220 24A bioMerieux, Lot 1084) wells containing bacterial suspension calibrated at the turbidity of 0.5 McFarland standard diluted at 10−3 dilution, and incubated at 36 ± 1 °C for 24 h. After the incubation, the content of the wells was removed, and the wells were thoroughly washed with sterile physiologic saline solution. The obtained biofilm was then fixed with 150 μL anhydrous methanol for analysis (Merck KGaA CAS No 67-56-1) for 5 min followed by the staining process with 1% Gram Crystal Violet (Biognost GC1-OT-250) for an additional 20 min interval before performing an additional plate washing step with water. Next, the fixed dye was solubilized with a 33% glacial acetic acid solution for analysis (Chimreactiv S.R.L. CAS 64-19-7) and the optical density (OD) was measured at a wavelength of 500 nm. Microplate wells without the plasmonic nanoplatform were prepared in the same experimental conditions as control samples. The experiment was performed in triplicate for each probe.
The reduction percent of the biofilm formation for
Staphylococcus aureus and
Escherichia coli was calculated using the following expression:
The correction was applied by subtracting the ODc, which stands for the mean of the 3 ODs of the negative controls plus 3 times the negative control standard deviation, from both of the ODs of the control and treated growth wells.
3.9. Characterization Methods
The UV-Vis extinction spectra of the colloidal AuNSs were recorded using a Jasco V-670 double-beam UV-Vis-NIR spectrophotometer (from Jasco International CO., Ltd. (Tokyo, Japan), with a 2 nm bandwidth and 1 nm spectral resolution. The recorded spectra were analysed with the Spectra Manager software. The size and morphology of the synthesized AuNSs in aqueous solution were then examined using a FEI Tecnai F20 field emission Transmission Electron Microscope (TEM), operating at an accelerating voltage of 200 kV and equipped with Eagle 4k CCD camera. The colloid was added dropwise onto a carbon film covered copper grid for TEM analyses. Dynamic light scattering (DLS) and Zeta Potential measurements of the colloidal AuBPs were performed using a Nano ZS90 Zetasizer analyzer from Malvern Instruments equipped with a He-Ne laser (633 nm, 5 mW). The used analysis parameters were a scattering angle of 90° and temperature of 25 °C. All samples were measured three times and the mean value has been reported.
After the controlled immobilization of the AuNSs on the Whatman paper, the plasmonic responses of the new as-formed plasmonic nanoplatforms were collected using a portable Ocean Optics USB 4000 optical UV-Vis spectrophotometer coupled to a ZEISS Axio Observer Z1 inverted microscope with 10× ZEISS objective (NA = 0.45) through an optical fiber with a core diameter of 600 μm. The extinction spectra were recorded in absorption mode, using 5 accumulations and 50 milliseconds integration time, the spectral resolution of the spectrophotometer being 0.2 nm. Subsequently, the morphology and the uniformity of the new nanoplatforms were investigated by Scanning Electron Microscopy (SEM) using a FEI Quanta 3D FEG dual beam scanning electron microscope operating at an accelerating voltage of 30 kV. The plasmonic paper were sputtered using a Q150R ES automatic Sputter Coater, in an argon atmosphere, with 5 nm gold layer for 10 min prior to the SEM investigation in order to inhibit charging, reduce thermal damage and improve the secondary electron signal required for topographic examination in the SEM. High Resolution TEM (HR-TEM) images were then recorded using a Jeol 2010F electron microscope working at 200 kV. For the HRTEM observation, the paper-based plasmonic nanoplatforms were wetted with alcohol, then scratched with a scalpel, and the debris was suspended in alcohol using ultra-sonication for 15 min to disperse it. A droplet of the solution was dribbled onto a holey carbon grid 300 mesh microscopy grid and allowed to dry.
Fluorescence emission measurements were collected at room temperature using for Jasco LP-6500 spectrofluorometer containing an epifluorescence accessory (EFA 383 module) with a 1 nm spectral resolution, and equipped with a DC-powered 150W Xenon lamp as excitation source. The excitation and emission bandwidths were fixed at 3 nm. Fluorescence spectra were recorded in the wavelength range of 290–500 nm, employing a fixed excitation wavelength at 280 nm.
In-vitro fluorescence images were taken using a confocal microscope (Andor DSD2 Confocal Unit) mounted on an epifluorescence microscope, Olympus BX-51. Nucleus images were recorded using an appropriate DAPI/Hoechst filter cube (excitation filter 390/40 m, dichroic mirror 405 nm and emission filter 452/45 nm) and the actin filaments were evidenced using a GFP/FITC filter cube (excitation filter 466/40 nm, dichroic mirror 488 nm and emission filter 525/54 nm). Images were further processed using the ImageJ software.
4. Conclusions
In conclusion, in this paper, we synergistically combined the advantage of the positively-charged gold nanospheres electrostatically immobilized onto a Whatman paper, as miniaturized plasmonic transducers, with the synthetic RRWHRWWRR-NH2 polypeptide, as potent antimicrobial peptide, to obtain an efficient nanoplatform able to inhibit both the microbial activity and biofilm formation of two reference bacterial strains: Staphylococcus aureus ATCC 12600 and Escherichia coli ATCC 25922, respectively. Specifically, after the nanoparticles’ loading onto the negatively-charged cellulose fibres, as a result of an easy immersion approach, the as-engineered plasmonic paper was optically and morphologically characterized to prove the well-conserved optical response, as well as the uniform distribution of the nanoparticles onto the 3D flexible paper fibre scaffold. Finally, the antimicrobial activity of the grafted P2 peptide onto the plasmonic paper was proved to be significantly enhanced, namely 100%, against both microorganisms tested. Moreover, the plasmonic paper significantly reduced the in-vitro biofilm formation of Staphylococcus aureus up to 79% and Escherichia coli up to 24% compared to without plasmonic paper. Our functionalized plasmonic paper-based antimicrobial nanoplatform relies on a simple and cheap fabrication method which integrates biocompatibility features and highly efficient anti-microbial activity, thus becoming a good candidate for further use as an antimicrobial nanoplatform.